The LCP AI risk stratification tool uses deep learning and radiomics to analyze CT images to produce a user-friendly cancer risk score. LCP AI is the world’s only FDA- cleared and UKCA/CE-marked reimbursable radiomics AI solution for lung cancer diagnosis.

Lung Cancer Prediction (LCP) AI

Optellum is a lung health company developing a lung precision care platform to redefine the efficient management, early diagnosis, and optimal care for people with disease. Lung cancer is one of the deadliest diseases, and US veterans have a higher prevalence of advanced lung cancer compared to the general population. Ensuring that veterans are supported in accessing the best possible care, and their healthcare providers are supported in delivering it, is essential to preventing disease progression and poor health outcomes from transpiring.{class="lead"}

Optellum’s Virtual Nodule Clinic (VNC) is the world’s only FDA-cleared AI-powered solution for managing and prioritizing lung nodules to help diagnose lung cancer early. VNC offers a triple-pronged approach: find, manage, and prioritize. Optellum’s Patient Discovery AI makes identifying people with lung nodules faster, with 98% specificity and 100% sensitivity. VNC’s workflow management system enables healthcare providers to track and manage their cases with seamless efficiency. In addition, Optellum’s risk stratification tool, Lung Cancer Prediction (LCP) AI, analyses nodules on CT images to produce a cancer risk score to support clinicians and reinforce decisions on next steps.

The tools and technology being developed by Optellum are defining how we care for our veterans. Having the capability of finding lung cancer with precision and specificity is vital. Early detection is key.

SDV Medical is a proud partner and distributor of Optellum’s groundbreaking AI-powered lung health platform because we are committed to advancing early cancer detection and improving patient outcomes. Our shared mission to empower healthcare providers with innovative tools aligns with Optellum’s vision for redefining lung disease diagnosis and care. With solutions like the Virtual Nodule Clinic and the FDA-cleared Lung Cancer Prediction AI®, Optellum is transforming how providers detect and manage lung cancer—delivering precision insights when they matter most.

Lung Cancer Prediction (LCP) AI

Contact sales to plan for the acquisition of this equipment.